The Advisory Board Company (ABCO) Issues Earnings Results
The Advisory Board Company (NASDAQ:ABCO) released its earnings results on Tuesday. The business services provider reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by $0.08, Morningstar.com reports. The business had revenue of $200.30 million during the quarter, compared to the consensus estimate of $196.16 million. The Advisory Board had a net margin of 12.78% and a return on equity of 14.48%. The business’s revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.46 earnings per share. The Advisory Board updated its FY17 guidance to $1.80 – $2.10 EPS.
The Advisory Board (ABCO) opened at 52.05 on Wednesday. The Advisory Board has a one year low of $24.85 and a one year high of $59.50. The company has a market capitalization of $2.11 billion, a price-to-earnings ratio of 21.09 and a beta of 1.33. The firm’s 50-day moving average price is $54.47 and its 200 day moving average price is $49.35.
Several large investors have recently modified their holdings of ABCO. Victory Capital Management Inc. acquired a new stake in shares of The Advisory Board during the first quarter worth about $109,000. Rockefeller Financial Services Inc. acquired a new stake in shares of The Advisory Board during the second quarter worth about $137,000. Howard Hughes Medical Institute acquired a new stake in shares of The Advisory Board during the first quarter worth about $158,000. Asset Management One Co. Ltd. acquired a new stake in shares of The Advisory Board during the first quarter worth about $159,000. Finally, Ameritas Investment Partners Inc. acquired a new stake in shares of The Advisory Board during the first quarter worth about $166,000.
Several equities analysts have recently issued reports on the company. BidaskClub lowered The Advisory Board from a “hold” rating to a “sell” rating in a report on Saturday. Zacks Investment Research lowered The Advisory Board from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 25th. Robert W. Baird reaffirmed an “outperform” rating and issued a $65.00 target price (up from $57.00) on shares of The Advisory Board in a report on Sunday, July 9th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $53.00 target price (up from $48.00) on shares of The Advisory Board in a report on Thursday, July 6th. Finally, Credit Suisse Group upped their target price on The Advisory Board from $54.00 to $55.00 and gave the company an “outperform” rating in a report on Monday, May 15th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $50.33.
The Advisory Board Company Profile
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.
Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.